|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.13 SEK | +4.00% |
|
-11.44% | -42.22% |
| Apr. 26 | Cell Impact AB Signs Agreement Valued At SEK 3.2 Million | CI |
| Apr. 25 | Cell Impact AB Announces Board and Committee Changes | CI |
Cell Impact AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 47.26 million compared to SEK 77.42 million a year ago. Revenue was SEK 48.58 million compared to SEK 93.03 million a year ago.
Net loss was SEK 121.4 million compared to SEK 104.22 million a year ago. Basic loss per share from continuing operations was SEK 1.11 compared to SEK 1.38 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -42.22% | 7.01M | |
| +54.30% | 3.74B | |
| +8.22% | 2.04B | |
| +0.43% | 1.99B | |
| -6.79% | 1.91B | |
| -5.37% | 1.38B | |
| +15.70% | 1.36B | |
| -16.05% | 1.38B | |
| -28.65% | 1.3B | |
| -17.02% | 1.24B |
CELL IMPACT AB 
